Drug adherence in chronic kidney diseases and dialysis. - Wikidata - awgldk - TriplyDB

Drug adherence in chronic kidney diseases and dialysis.

Drug adherence in chronic kidney diseases and dialysis.

http://www.wikidata.org/entity/Q38187107

about

Patient's perceptions of chronic kidney disease and their association with psychosocial and clinical outcomes: a narrative review Nonadherence to Medication Therapy in Haemodialysis Patients: A Systematic Review Integral pharmacological management of bone mineral disorders in chronic kidney disease (part I): from treatment of phosphate imbalance to control of PTH and prevention of progression of cardiovascular calcification.Resilience, religiosity and treatment adherence in hemodialysis patients: a prospective study.Systematic underutilisation of secondary preventive drugs in patients with acute coronary syndrome and reduced renal function.Illness Perceptions, Medication Beliefs, and Adherence to Antiretrovirals and Medications for Comorbidities in Adults With HIV Infection and Hypertension or Chronic Kidney Disease.An integrative review of the methodology and findings regarding dietary adherence in end stage kidney disease.Efficiency of delivery observed treatment in hemodialysis patients: the example of the native vitamin D therapy.Renal pharmacists' perceptions and current practices of assessing medication adherence in dialysis patients.Effect of Contract Compliance Rate to a Fourth-Generation Telehealth Program on the Risk of Hospitalization in Patients With Chronic Kidney Disease: Retrospective Cohort Study.Selective Nanoparticle Targeting of the Renal Tubules.Association between medication adherence and clinical outcomes in patients with chronic kidney disease: a prospective cohort study.Improving treatment satisfaction to increase adherence.Self-reported Medication Adherence and CKD Progression.The Effect of Quality of Life on Medication Compliance Among Dialysis Patients.Role of etelcalcetide in the management of secondary hyperparathyroidism in hemodialysis patients: a review on current data and place in therapy.Inflammation down-regulates CYP3A4-catalysed drug metabolism in hemodialysis patients.Blood pressure control in chronic kidney disease: A cross-sectional analysis from the German Chronic Kidney Disease (GCKD) study Management practice, and adherence and its contributing factors among patients with chronic kidney disease at Tikur Anbessa Specialized Hospital: A hospital-based cross-sectional study

P2860

Q26747602-51249ED6-E5A2-40E1-AF7D-941E50B437D9 Q26774337-F59CC060-A59B-479F-9C49-C2E68AFAB899 Q38828902-D459E4EE-FBAE-4242-AD08-63DE6735856B Q39291831-9006F70E-FCF0-4432-A3B8-6B7CBD77377E Q40336961-539CCB81-7D5E-4617-8B0C-1A1D3AD8AF2E Q40481281-EFB9083F-B357-44EB-9AB7-D7D6DF2805EA Q42644161-D9D89EF5-7649-45DE-AF5B-7BCA4DB18D82 Q43541732-69C7A823-63C8-4BB4-8994-159FA670F3A7 Q47796130-4F1EA571-110B-4E73-B9D5-493C0E044E36 Q48172944-756C8707-DD42-4AAA-86FF-1DAE85020593 Q48602509-01BF12B7-3E20-481F-AF9D-F6B245498AF8 Q50194686-29EC1256-AC77-498A-BB07-C3B058049283 Q50873211-AD4498C2-DDC0-4BE2-A66F-69038D74A04B Q55284951-D7A6DA22-7345-49DB-ACDE-56F40D4300FE Q55410791-5CD8C778-A023-4A31-B5E3-FC2A8A743B6D Q55413395-E52AEC9B-41F8-4FE3-ADB8-B45F488C57F2 Q55439721-83FA2C3A-09D3-4C72-8FD5-2729E2FE86B4 Q58765668-33B34BF6-5AB8-4113-9D05-8FAE2767957C Q58866156-0E30B161-50DE-4AFA-BCCD-1C878E0A676D

P2860

Drug adherence in chronic kidney diseases and dialysis.

http://www.wikidata.org/entity/Q38187107

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Drug adherence in chronic kidney diseases and dialysis.

@en

type

label

Drug adherence in chronic kidney diseases and dialysis.

@en

prefLabel

Drug adherence in chronic kidney diseases and dialysis.

@en

P1433

Q38187107-50BAB923-BA32-4746-A150-6A3527DFC2B0

P1476

Q38187107-C90F7258-C307-4D1C-8C3D-7E6C05040A54

P2093

Q38187107-9E1EBE93-089C-41F9-BB05-80DB708DE74B

Q38187107-F22AA2DF-02E2-49BA-A612-FD2376C73481

P2860

Q38187107-0A8247D5-2C93-405C-9962-B60B7B41D911

Q38187107-11B70567-F2E0-4F35-89C6-F05F9810180E

Q38187107-1734F193-187F-43E4-852D-F5AE2770DB4D

Q38187107-1D3999A3-7747-4057-8BFE-155174E83EFB

Q38187107-26962864-B460-455F-9403-C184481C8DC9

Q38187107-2898B9ED-97AB-4A61-AC94-7995898153E9

Q38187107-2CC6F23C-89EA-4911-9B2A-008321E21CE7

Q38187107-3B8BA0A3-F147-40E2-9881-64B9ADE95870

Q38187107-4E248D2D-6690-4AFA-8B48-B846A5007BD6

Q38187107-5283D5DF-E327-4850-8A71-5292C3BB5C21

P304

Q38187107-26E9F5A4-4608-4256-B959-3D0408B1600D

P31

Q38187107-41C7A2D4-1C0A-4D5A-945E-D04A2660A0A5

P356

Q38187107-501B3FB2-4E8C-4D8B-9EB0-35D69397EF7B

P407

Q38187107-D0E2D8D4-4BA5-4829-AC30-F64299B3C714

P433

Q38187107-4EF44595-1C6C-4290-AF3F-0EBF8EC90F35

P478

Q38187107-0F62DA4E-024F-48E1-A849-111FBC521B2D

P50

Q38187107-1B5B0BFA-40CD-4432-AEA1-1CDAC8700634

Q38187107-ECC32DE2-6199-4A03-8D11-15E929E38884

P577

Q38187107-66C8A8AD-2EF6-4C2F-85D6-038CADA11829

P698

Q38187107-0C5DEA5F-C1BE-4CAB-9EF7-D62C904DA36F

P921

Q38187107-2EC90B78-BD05-4914-AC9C-3D7A4D7A0C0F

P356

P1433

Nephrology Dialysis Transplantation

P1476

Drug adherence in chronic kidney diseases and dialysis.

@en

P2093

Michel Burnier

http://www.w3.org/2001/XMLSchema#string

Valerie Santschi

http://www.w3.org/2001/XMLSchema#string

P2860

Patterns of medication use in the RRI-CKD study: focus on medications with cardiovascular effects

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

A systematic review of the prevalence and determinants of nonadherence to phosphate binding medication in patients with end-stage renal disease.

Depression is an important contributor to low medication adherence in hemodialyzed patients and transplant recipients.

Low medication adherence and hypertension control among adults with CKD: data from the REGARDS (Reasons for Geographic and Racial Differences in Stroke) Study.

Clinical measures identify vitamin D deficiency in dialysis.

Medication adherence behavior and priorities among older adults with CKD: a semistructured interview study.

ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).

Impact of pharmacist care in the management of cardiovascular disease risk factors: a systematic review and meta-analysis of randomized trials.

Vitamin D supplementation in chronic kidney disease: a systematic review and meta-analysis of observational studies and randomized controlled trials.

P304

39-44

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/NDT/GFU015

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P50

Grégoire Wuerzner

P577

2014-02-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24516224

http://www.w3.org/2001/XMLSchema#string

P921